Logo

American Heart Association

  2
  0


Final ID: Su1012

Race-Dependent Association of Inflammation and Cholesterol with Cardiovascular Mortality in US Population

Abstract Body (Do not enter title and authors here): Background: Inflammation and cholesterol jointly contribute to cardiovascular disease and mortality. The relative contributions of inflammation and cholesterol to the risk of future cardiovascular events might shift according to pre-existing traits of each individual. Whether the association of inflammation and cholesterol with cardiovascular mortality differ by race remains unclear.

Method:We sampled 12,726 participants from NHAENS III who were categorized as non-Hispanic White, non-Hispanic Black or Mexican Americans. In all race groups, we used the Cox proportional hazard regression model to relate log-transformed CRP and LDL-C levels to CVD deaths. All models simultaneously included CRP and LDL-C, and were adjusted for age, current smoking, hypertension, diabetes mellitus, body mass index, lipid-lowering medications, total cholesterol and family income.

Results12,726 participants (53.4% female, mean age 46.8 ± 19.7 years) including 5648 non-Hispanic White (44.4%), 3484 non-Hispanic Black (27.4%) and 3594 Mexican-American (28.2%) were followed up for a median 26.3 years , and 1905 cardiovascular deaths were documented. After adjusting for cardiometabolic risk factors, per 1 SD increase in log-transformed CRP was associated with 14% (HR 1.14 [95% CI, 1.08-1.21], P < 0.001) and 13% (HR 1.13 [95% CI, 1.04-1.23], P = 0.001) higher risk of CVD mortality in non-Hispanic White and non-Hispanic Black respectively, while the association was neutral in Mexican American. Notably, per 1 SD increase in LDL-C was not associated with CVD mortality in all race groups (P > 0.05 for all).

ConclusionAfter a follow up of median 26.3 years, we found that, in non-Hispanic White and Black individuals, but not in Mexican American, inflammatory was a stronger predictor of cardiovascular mortality, compared to cholesterol.
  • Li, Pengfei  ( Qingdao University , Qingdao , China )
  • Zhang, Yiwen  ( Qingdao University , Qingdao , China )
  • Ji, Hongwei  ( Tsinghua University , Beijing , Beijing , China )
  • Author Disclosures:
    Pengfei Li: No Answer | Yiwen Zhang: DO NOT have relevant financial relationships | Hongwei Ji: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Novel Roles for Lipids and Lipoproteins in Cardiovascular Diseases

Sunday, 11/17/2024 , 03:15PM - 04:15PM

Abstract Poster Session

More abstracts on this topic:
Abatacept prevents anti-PD-1-induced inflammatory heart failure development after myocardial ischemic injury in mice

Gergely Tamas, Buzas Edit, Neilan Tomas, Ferdinandy Peter, Varga Zoltan, Drobni Zsofia, Kovacs Tamas, Sayour Nabil, Toth Viktoria Eva, Onodi Zsofia, Kocsis Marton, Fekete Nora, Pallinger Eva

84 Immune checkpoint profiling in major aortic diseases leads to identification of potential roles of CD155-CD206 pathway in suppressing inflammation and immune responses

Shao Ying, Saaoud Fatma, Xu Keman, Lu Yifan, Jiang Xiaohua, Wang Hong, Yang Xiaofeng

More abstracts from these authors:
Thirty-Year Prevalence and Prognosis of the Cardiovascular-Kidney-Metabolic Syndrome in U.S. Females and Males

Ji Hongwei, Wong Tien, Sabanayagam Charumathi, Matsushita Kunihiro, Cheng Ching-yu, Rim Tyler Hyungtaek, Sheng Bin, Li Huating, Tham Yih Chung, Cheng Susan

Cardiovascular Prognosis of Statin Users Developing Diabetes in Secondary Prevention: A Prospective Multicenter Study

Zhang Yiwen, Li Pengfei, Ji Hongwei

You have to be authorized to contact abstract author. Please, Login
Not Available